期刊档案 · MEDICINE, RESEARCH & EXPERIMENTAL
Discovery Medicine
ISSN 1539-6509 · eISSN 1944-7930 · Timonium, MD : Discovery Medicine · UNITED STATES · Monthly · 创刊 2001
Discovery Medicine 中科院 医学 4区（2025 年升级版），影响因子 2.73，完全开放获取，收取 APC，金额未公布，投稿社区反馈审稿6–12 周，录用比例较易（社区反馈），2025 年发文 260 篇，SCIE 收录。
研究范围
研究范围与定位
Discovery Medicine 由 Timonium, MD : Discovery Medicine 出版，属中科院医学大类（2025 升级版4区）。按 OpenAlex 近年发文统计，该刊主要发表 Ferroptosis and cancer prognosis、Autophagy in Disease and Therapy、Immune cells in cancer 等主题的论文，这 3 个主题约占 22.9%，主导子领域为 Molecular Biology。（根据 OpenAlex 主题统计与中科院分区数据生成）
Discovery Medicine publishes innovative, provocative, and disruptive ideas, insights, and discoveries in clinical medicine, preclinical research, basic biomedical sciences, and all other fields of life sciences.
摘自期刊官网 Aims & Scope
研究方向（LetPub）：MEDICINE, RESEARCH & EXPERIMENTAL
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Ferroptosis and cancer prognosisMedicine12.1%
- Autophagy in Disease and TherapyMedicine5.6%
- Immune cells in cancerImmunology and Microbiology5.2%
- Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology4.9%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology4.7%
- Inflammasome and immune disordersBiochemistry, Genetics and Molecular Biology4.7%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology4.5%
- Cancer-related gene regulationBiochemistry, Genetics and Molecular Biology4.3%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 医学：研究与实验MEDICINE, RESEARCH & EXPERIMENTAL | 4 区 |
Top 期刊：否综述期刊：否
《新锐期刊分区表》（ 2026年3月发布）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 医学：研究与实验MEDICINE, RESEARCH & EXPERIMENTAL | 4 区 |
Top 期刊：否综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 医学：研究与实验MEDICINE, RESEARCH & EXPERIMENTAL | 4 区 |
Top 期刊：否综述期刊：否
数据库收录
SCIELetPub
国际期刊预警名单：各版本均未列入LetPub
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子
- 2.73LetPub ·
- 影响因子（出版商公布）
- 3.2出版商官网 ·
- CiteScore 2026-06
- 5.4LetPub ·
- SJR 2026-06
- 0.81LetPub ·
- SNIP 2026-06
- 0.75LetPub ·
- h-index
- 25LetPub ·
- h-index
- 18OpenAlex ·
- i10-index
- 66OpenAlex ·
- 两年平均被引
- 2.14OpenAlex ·
- 自引率
- 3.1%LetPub ·
- Gold OA 文章占比
- 3.07%LetPub ·
发文规模
- 年文章数
- 247LetPub ·
逐年发文量 OpenAlex 统计 · 累计 838 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 235 | 163 | 12 |
| 2025 | 260 | 160 | 325 |
| 2024 | 228 | 185 | 1,208 |
| 2023 | 115 | 113 | 791 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
- 平均审稿速度（社区反馈）
- 较慢,6-12周LetPub ·
- 平均录用比例（社区反馈）
- 较易LetPub ·
- 投稿到首次决定
- 8 天出版商官网 ·
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
完全开放获取LetPub
所有文章开放获取，通常向作者收取文章处理费（APC）。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| 出版商官网 | 有，金额未公布 | — | — |
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
接收的文章类型11 种，含篇幅限制
- articleArticle An article is a report summary based on original research or investigation, usually a form of presentation that advances theoretical, empirical, experim…未说明篇幅
- case reportA case report is a detailed report based on rare diseases or complications, used to describe the symptoms, signs, pathological characteristics, diagnosis, treat…未说明篇幅
- commentaryContent Scope Discovery Medicine publishes innovative, provocative, and disruptive ideas, insights, and discoveries in clinical medicine, preclinical research, …未说明篇幅
- editorialContent Scope Discovery Medicine publishes innovative, provocative, and disruptive ideas, insights, and discoveries in clinical medicine, preclinical research, …未说明篇幅
- lettersLetters Letters are short communications that provide critical comments, additional perspectives, or alternative viewpoints on articles previously published in …未说明篇幅
- meta-analysisContent Scope Discovery Medicine publishes innovative, provocative, and disruptive ideas, insights, and discoveries in clinical medicine, preclinical research, …未说明篇幅
- original researchContent Scope Discovery Medicine publishes innovative, provocative, and disruptive ideas, insights, and discoveries in clinical medicine, preclinical research, …未说明篇幅
- protocolContent Scope Discovery Medicine publishes innovative, provocative, and disruptive ideas, insights, and discoveries in clinical medicine, preclinical research, …未说明篇幅
- reviewContent Scope Discovery Medicine publishes innovative, provocative, and disruptive ideas, insights, and discoveries in clinical medicine, preclinical research, …正文 ≤ 7,000 词
- systematic reviewContent Scope Discovery Medicine publishes innovative, provocative, and disruptive ideas, insights, and discoveries in clinical medicine, preclinical research, …未说明篇幅
- viewpointContent Scope Discovery Medicine publishes innovative, provocative, and disruptive ideas, insights, and discoveries in clinical medicine, preclinical research, …未说明篇幅
官网政策摘录作者资格、利益冲突、数据可用性、许可与版权、同行评审、预印本
- 作者资格 3.3.2 Author Contributions
An 'author' is generally considered to be someone who has made substantive intellectual contributions to a published study. According to the ICMJE guidelines, to qualify as an author, one should have (i) made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; and (ii) been involved in drafting the manuscript or revising it critically…
原文 ↗出版商官网 ·- 利益冲突 3.3.6 Conflict of Interest
Authors must include a statement fully disclosing any known or potential conflicts of interest. More details.
原文 ↗出版商官网 ·- 数据可用性 3.3.1 Availability of Data and Materials
To promote transparency, authors are encouraged to state the availability of their data in the submission. This may be a requirement of the funding body or institution. If the data are unavailable for access or unsuitable for posting, authors should indicate the reason during the submission process (for example, by stating that the research data is confidential). More details.
原文 ↗出版商官网 ·- 许可与版权
Copyright and permissions specifications are provided in Copyright & License. 模型摘要
9. Copyright and Permissions For specifications, please refer to Copyright & License.
原文 ↗出版商官网 ·- 同行评审 7. Peer-Review Process
Peer-review process specifications are provided in The Discovery Medicine Editorial Process. 模型摘要
For specifications, please refer to The Discovery Medicine Editorial Process.
原文 ↗出版商官网 ·- 预印本 5. Preprint
Preprint policy: authors should disclose detailed information about the article published on the preprint server, including URL link and licensing terms; once published, authors must update the preprint publication reference including DOI and URL link to the published version. 模型摘要
When submitting the manuscript to Discovery Medicine, authors should disclose the detailed information about the article published on the preprint server, including a URL link and licensing terms. Once the article is published, it is the authors' responsibility to ensure that the publication reference on the preprint servers is updated, including the DOI and a URL link to the published version of …
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Timonium, MD : Discovery Medicine
- 出版国家或地区
- UNITED STATES
- 出版语言
- English
- 出版周期
- Monthly
- 创刊年份
- 2001
- ISSN
- 1539-6509
- 电子版 ISSN
- 1944-7930
- 官方链接
- 期刊主页 ↗OpenAlex
- 投稿系统 ↗LetPub
- 作者指南 ↗LetPub
- 专刊 / 特刊征稿 ↗出版商官网
常见问题
关于 Discovery Medicine 的常见问题
Discovery Medicine 是中科院几区期刊？
2025 年升级版分区表中，Discovery Medicine 为医学 4区，小类 医学：研究与实验 4 区。2026 年新锐版分区表中为医学 4区。不同版本与大小类分区不能混用。
Discovery Medicine 的影响因子是多少？
LetPub 汇总的最新公布影响因子为 2.73，CiteScore 为 5.4，h-index 为 18。
Discovery Medicine 的审稿周期多长？
投稿社区反馈的平均审稿速度为6–12 周，平均录用比例反馈为“较易”。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Discovery Medicine 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Discovery Medicine 被 SCIE 收录。
Discovery Medicine 是开放获取期刊吗？版面费多少？
Discovery Medicine 为完全开放获取。收取 APC，金额未公布。
来源与更新
本页事实来自 LetPub、OpenAlex、出版商官网；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-28 归档）。最近更新：。